OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC

Clinical trial NCT04713514 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04713514
Sponsor: ARCAGY/ GINECO GROUP
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum-sensitive Ovarian Cancer Relapsed Ovarian Cancer

Start date: 2021-08-05
Primary completion: 2025-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.